de Vries F, Otten LS, Piet B, Franssen EJF, et al. Early pembrolizumab clearance as prognostic biomarker for non-response in patients with advanced non-small cell lung cancer. Int J Cancer 2025 Jul 24. doi: 10.1002/ijc.70052.
PMID: 40704757